A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

Conditions: Onychomycosis Interventions: Drug: ATB1651-102- Cohort 1; Drug: ATB1651-102- Cohort 2; Drug: ATB1651-102- Cohort 3; Drug: ATB1651-102- Cohort 4; Drug: Placebo Sponsors: AmtixBio Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials